NCT02317705 2022-06-21Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian CancerOn Target Laboratories, LLCPhase 2 Completed48 enrolled 10 charts
NCT03180307 2022-02-04OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian CancerOn Target Laboratories, LLCPhase 3 Completed140 enrolled 11 charts 1 FDA